Log In
Print
BCIQ
Print
Print this Print this
 

Xeloda, capecitabine (R340, RG340)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral prodrug form of 5-fluorouracil (5-FU)
Molecular Target Thymidylate synthase
Mechanism of ActionThymidylate synthase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today